Trial intelligence / Profile preview

Comtess vs Cabaseril in Parkinson's Disease with Wearing-Off

NCT00247247Phase 4Completed

Sponsor
Orion Corporation
Start
Dec 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of entacapone in Parkinson's disease (PD), sponsored by Orion Corporation. Started Dec 2002; status: completed.

02

Drugs

entacapone
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT00247247.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00247247.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call